Themis Medicare Share Price Today | Stock Price & Themis Medicare Share Screener
As of November 19, 2026, the live Themis Medicare share price (NSE: THEMISMED) is ₹96.98 on NSE and ₹97.36 on BSE, up 0.50% from the previous close, with shares trading between ₹96.20 and ₹98.00 in today's trading session, and a 52-week range of ₹66.07–₹133.07. Track Themis Medicare networth to gauge the company's total market size. Use the Themis Medicare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Themis Medicare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹87 and net income of ₹9, with EBITDA of ₹14, an operating margin of 5.0% and a profit margin of 10.3%.
Themis Medicare Share Price Chart
Track the current stock price of Themis Medicare with an interactive chart. Analyse THEMISMED share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Themis Medicare stock quote in one place.
The quote of ₹96.98 sits between the 52-week low of ₹66.07 and the 52-week high of ₹133.07, and the latest session moved 0.50% from the previous close.
Themis Medicare Company Profile - Fundamental Screener
Screen Themis Medicare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for THEMISMED shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE083B01024.
Company Details
Classification
Identifiers and Leadership
Themis Medicare Balance Sheet Screener
Screen THEMISMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹598, up from ₹588 in 2025.
Latest statistics put total assets at ₹598 and shareholder funds at ₹399, with a leverage ratio of 0.25.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 598 | 588 | 566 | 514 | 428 | 371 | 350 | 314 | 305 | 289 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 167 | 172 | 168 | 162 | 144 | 133 | 116 | 123 | 126 | 124 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 33 | 29 | 34 | 35 | 31 | 24 | 12 | 9 | 12 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 399 | 403 | 378 | 339 | 288 | 219 | 183 | 158 | 169 | 152 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 389 | 393 | 369 | 330 | 278 | 209 | 174 | 149 | 160 | 143 |
Themis Medicare Income Statement Screener - Profit & Revenue Analysis
Screen Themis Medicare income statement and profit fundamentals. Analyze THEMISMED quarterly results. Themis Medicare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹87 and net profit was ₹9, equal to earnings per unit of ₹0.96, at an operating margin of 5%.
In that period expenses were ₹73, interest cost ₹3 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹184 and net profit of ₹25.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 87 | 184 | 97 | 73 | 99 | 83 | 97 | 103 | 130 | 123 | 95 | 85 | 103 | 111 | 89 |
| Expenses | 73 | 139 | 84 | 79 | 108 | 81 | 81 | 89 | 94 | 100 | 88 | 70 | 75 | 92 | 74 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 14 | 44 | 13 | -6 | -9 | 2 | 16 | 14 | 36 | 23 | 7 | 16 | 28 | 19 | 14 |
| Operating Profit % | 5.00% | -60.00% | 6.00% | -11.00% | -10.00% | -4.00% | 10.00% | 10.00% | 24.00% | 15.00% | 6.00% | 13.00% | 22.00% | 12.00% | 10.00% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 3 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 9 | 39 | 8 | -11 | -14 | -4 | 10 | 9 | 31 | 18 | 2 | 10 | 23 | 14 | 8 |
| Tax | 0 | 14 | 1 | -2 | 0 | 0 | 0 | 2 | 7 | 4 | 1 | 2 | 4 | 3 | 1 |
| Net Profit | 9 | 25 | 7 | -10 | -14 | -4 | 10 | 7 | 25 | 14 | 1 | 8 | 18 | 11 | 7 |
| EPS | 0.96 | 2.67 | 0.77 | -1.05 | -1.54 | -0.39 | 1.10 | 0.72 | 2.68 | 1.55 | 0.06 | 9.13 | 19.77 | 12.30 | 0.80 |
Themis Medicare Cash Flow Screener - Liquidity Fundamentals
Screen THEMISMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹3, and net cash flow was an outflow of ₹2.
Over the same period, investing activities used ₹3 and financing activities provided ₹4.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -3 | 35 | 22 | 16 | 34 | 57 | 0 | 11 | 8 | -2 |
| Investing Activities | -3 | -12 | -16 | -24 | -16 | -16 | -6 | -4 | 0 | -4 |
Financing and Net Cash | ||||||||||
| Financing Activities | 4 | -26 | -9 | 0 | -18 | -26 | 7 | -10 | -9 | 5 |
| Net Cash Flow | -2 | -3 | -3 | -8 | 1 | 16 | 2 | -3 | -1 | 0 |
Themis Medicare Shareholding Pattern Screener
See Themis Medicare shareholding pattern with promoter, FII, and DII holdings. Check Themis Medicare promoter holding and ownership changes for THEMISMED on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 67.11%, foreign institutions 0.11%, domestic institutions 0.01% and the public 23.73%, spread across 21,818 shareholders.
The shareholder count was 21,818 in 2026-Mar, compared with 21,267 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 67.11% | 67.11% | 67.11% | 67.15% | 67.15% | 67.15% | 67.11% | 67.15% |
Institutional Investors | ||||||||
| FII Holding | 0.11% | 0.01% | 0.01% | 0.14% | 0.10% | 0.06% | 0.05% | 0.03% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.73% | 23.57% | 23.26% | 23.93% | 24.14% | 23.97% | 24.02% | 23.31% |
| Other Holding | 9.05% | 9.30% | 9.62% | 8.77% | 8.60% | 8.80% | 8.81% | 9.49% |
| Shareholder Count | 21,818 | 21,267 | 20,126 | 17,889 | 19,335 | 22,490 | 22,576 | 11,295 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Themis Medicare. Themis Medicare dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.50%, compared with ₹0.50 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹0.50 and ₹0.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.50 | 0.50% |
| 2025-March | ₹0.50 | 0.76% |
| 2024-March | ₹0.50 | 0.34% |
| 2023-March | ₹5.00 | 2.29% |
| 2022-March | ₹5.00 | 4.24% |
| 2021-March | ₹4.30 | 4.59% |
| 2020-March | ₹1.75 | 6.22% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Themis Medicare Stock Index Membership - Nifty & Sensex
See which indices include Themis Medicare stock. Check THEMISMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 2 indices, including BSE INDEX BSE HC.
Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP.
Complete Index List
Themis Medicare Market Events Screener - Corporate Actions
Get Themis Medicare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Themis Medicare stock events that may affect THEMISMED share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.
It is followed by Annual General Meeting dated September 30, 2026 and Dividend dated September 23, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-14 | 2026-11-14 | Quarterly Result Announcement | NA | 10.69% |
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -9.91% |
| 2026-09-23 | 2026-09-23 | Dividend | ₹ 0.50 /share | 8.38% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 3.32% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | 13.63% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 7.49% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -1.41% |
| 2025-09-12 | 2025-09-12 | Annual General Meeting | NA | -1.60% |
| 2025-09-04 | 2025-09-05 | Dividend | ₹ 0.50 /share | -41.32% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | -8.21% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 25.64% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -15.07% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | 1.15% |
| 2024-07-22 | 2024-07-22 | Annual General Meeting | NA | 5.80% |
| 2024-07-12 | 2024-07-15 | Dividend | ₹ 0.50 /share | 9.31% |
Themis Medicare Competitors Screener - Peer Stocks Comparison
Screen THEMISMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 451,123 | 41.10 | 61,674 | 12.69% | 11,565 | 63.60 |
| Divis Laboratories | 298,758 | 90.70 | 11,067 | 13.95% | 2,568 | 78.53 |
| Torrent Pharmaceuticals | 179,477 | 84.50 | 13,886 | 20.34% | 2,138 | 47.27 |
| Laurus Labs | 125,590 | 98.10 | 6,868 | 22.01% | 890 | 69.60 |
| Zydus Life Science | 119,750 | 27.60 | 27,658 | 17.64% | 5,026 | 52.34 |
| Dr Reddys Laboratories | 115,603 | 41.70 | 35,059 | 3.90% | 4,158 | 70.24 |
| Cipla | 112,680 | 39.40 | 29,045 | 2.24% | 3,870 | 54.92 |
| Mankind Pharma | 109,085 | 48.40 | 14,636 | 14.85% | 1,938 | 65.43 |
| Aurobindo Pharma | 104,719 | 26.40 | 34,145 | 5.56% | 3,503 | 66.06 |
| Lupin | 90,877 | 17.30 | 29,039 | 26.75% | 5,356 | 44.92 |
Themis Medicare Company Announcements - News & Reports Screener
Screen THEMISMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated November 20, 2026 and November 20, 2026.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Investor Presentation | - | |
| 2026-11-20 | Results: Financial Results For The Quarter And Half Year Ended 30.09.2026 | - |
| 2026-11-20 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.11.2026 | - |
| 2026-11-02 | Update on board meeting | - |
| 2026-10-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-10-28 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-10-28 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-10-27 | Board Meeting Intimation for Consideration And Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2026 | - |
| 2026-10-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-10-24 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-10-24 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-10-23 | Announcement Under Regulation 30 - Updates | - |
| 2026-10-23 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-10-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-10-09 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-30 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-09-30 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
| 2026-09-30 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹96.98, within a 52-week range of ₹66.07 to ₹133.07. The P/E ratio is 23.40 and the P/B ratio is 2.55, with earnings per unit of ₹0.12. Market capitalisation stands at ₹905.16 Cr and the dividend yield is 0.50%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 21, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.